Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents

References

Page 1

	Year	Citations
Prevalence and Trends in Obesity Among US Adults, 1999-2000 Katherine M. Flegal JAMA	2002	6.2K
A role for melanin-concentrating hormone in the central regulation of feeding behaviour Daqing Qu, David S. Ludwig, Steen Gammeltoft, Nature NutritionBehavioral SciencesEndocrine MechanismBehavioral NeurosciencePhysiology	1996	1.3K
Mice lacking melanin-concentrating hormone are hypophagic and lean Masako Shimada, Nicholas A. Tritos, Bradford B. Lowell, Nature Energy HomeostasisEndocrine MechanismPhysiologyMetabolismEndocrinology	1998	1.2K
Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance David S. Ludwig, Nicholas A. Tritos, Jason Mastaitis, Journal of Clinical Investigation Functional LeptinMch MessageTransgenic MiceInsulin SignalingGastrointestinal Peptide Hormone	2001	620
The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines R. Gordon Gould, Walter A. Jacobs Journal of the American Chemical Society Certain Substituted QuinolinesDerivative (Chemistry)HeterocyclicAltmetric Attention ScoreOrganic Chemistry	1939	297
Obesity Drug Pipeline Not So Fat Trisha Gura Science Weight ManagementPsychopharmacologyPharmacotherapyExperimental PharmacologyObesity Prevention	2003	63
Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity Andrew J. Souers, Ju Gao, Dariusz Wódka, Bioorganic & Medicinal Chemistry Letters Urea-based IndazolesMedicinePhysiologyPharmacotherapyEndocrinology	2005	44
Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents Andrew C. Browning Expert Opinion on Therapeutic Patents Pharmaceutical ScienceHuman GrowthFood IntakePeptide SciencePharmacotherapy	2004	42

Page 1